Boston Scientific (NYSE:BSX) Earnings Information
Boston Scientific last released its earnings data on October 23rd, 2019. The medical equipment provider reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.01. The business had revenue of $2.71 billion for the quarter, compared to the consensus estimate of $2.68 billion. Its quarterly revenue was up 13.1% compared to the same quarter last year. Boston Scientific has generated $1.47 earnings per share over the last year and currently has a price-to-earnings ratio of 29.9. Boston Scientific has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2020 based off prior year's report dates.
Boston Scientific Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Boston Scientific (NYSE:BSX) Earnings Estimates
2019 EPS Consensus Estimate: $1.57
2020 EPS Consensus Estimate: $1.80
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2019 | 6 | $0.35 | $0.38 | $0.36 |
| Q2 2019 | 6 | $0.38 | $0.40 | $0.39 |
| Q3 2019 | 6 | $0.38 | $0.39 | $0.39 |
| Q4 2019 | 6 | $0.43 | $0.44 | $0.44 |
| Q1 2020 | 5 | $0.40 | $0.43 | $0.41 |
| Q2 2020 | 5 | $0.44 | $0.46 | $0.45 |
| Q3 2020 | 5 | $0.44 | $0.45 | $0.45 |
| Q4 2020 | 4 | $0.48 | $0.51 | $0.49 |
| Q1 2021 | 1 | $0.49 | $0.49 | $0.49 |
| Q2 2021 | 1 | $0.51 | $0.51 | $0.51 |
| Q3 2021 | 1 | $0.51 | $0.51 | $0.51 |
Boston Scientific (NYSE BSX) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | GAAP EPS | Revenue Estimate | Actual Revenue | Conference Call | Details |
|---|
2/5/2020
(Estimated) | | | | | | | | |
| 10/23/2019 | Q3 19 | $0.38 | $0.39 | $0.69 | $2.68 billion | $2.71 billion | Transcript | |
| 7/24/2019 | Q2 | $0.38 | $0.39 | $0.67 | $2.64 billion | $2.63 billion | Listen | |
| 4/24/2019 | 3/31/2019 | $0.36 | $0.35 | $0.40 | $2.54 billion | $2.49 billion | Listen | |
| 2/6/2019 | 12/31/2018 | $0.37 | $0.39 | $0.51 | $2.57 billion | $2.56 billion | Listen | |
| 10/24/2018 | 9/30/2018 | $0.34 | $0.35 | $0.39 | $2.40 billion | $2.39 billion | N/A | |
| 7/25/2018 | Q2 2018 | $0.34 | $0.41 | $0.42 | $2.47 billion | $2.49 billion | N/A | |
| 4/25/2018 | Q1 2018 | $0.32 | $0.33 | $0.45 | $2.34 billion | $2.38 billion | N/A | |
| 2/1/2018 | Q4 2017 | $0.34 | $0.34 | $1.13 | $2.39 billion | $2.41 billion | Transcript | |
| 10/26/2017 | Q3 2017 | $0.31 | $0.31 | $0.42 | $2.21 billion | $2.22 billion | N/A | |
| 7/27/2017 | Q2 2017 | $0.31 | $0.32 | $0.53 | $2.21 billion | $2.26 billion | N/A | |
| 4/27/2017 | Q1 2017 | $0.30 | $0.29 | $0.37 | $2.08 billion | $2.16 billion | N/A | |
| 2/2/2017 | Q416 | $0.29 | $0.30 | $0.51 | $2.16 billion | $2.19 billion | Listen | |
| 10/26/2016 | Q316 | $0.27 | $0.27 | $0.37 | $2.07 billion | $2.11 billion | Listen | |
| 7/28/2016 | Q216 | $0.27 | $0.27 | $0.69 | $2.05 billion | $2.13 billion | Listen | |
| 4/27/2016 | Q116 | $0.24 | $0.28 | $0.41 | $1.91 billion | $1.96 billion | Listen | |
| 2/4/2016 | Q415 | $0.25 | $0.26 | $0.63 | $2.00 billion | $1.98 billion | Listen | |
| 10/28/2015 | Q315 | $0.23 | $0.24 | $0.63 | $1.86 billion | $1.89 billion | Listen | |
| 7/23/2015 | Q215 | $0.21 | $0.22 | $0.36 | $1.83 billion | $1.84 billion | Listen | |
| 4/28/2015 | Q115 | $0.21 | $0.21 | $0.42 | $1.78 billion | $1.77 billion | Listen | |
| 2/4/2015 | Q414 | $0.21 | $0.22 | $0.38 | $1.91 billion | $1.89 billion | Listen | |
| 10/22/2014 | Q314 | $0.20 | $0.20 | $0.37 | $1.82 billion | $1.85 billion | Listen | |
| 7/24/2014 | Q214 | $0.20 | $0.21 | $0.42 | $1.87 billion | $1.87 billion | Listen | |
| 4/29/2014 | Q114 | $0.18 | $0.20 | $0.30 | $1.80 billion | $1.77 billion | Listen | |
| 2/4/2014 | Q4 2013 | $0.19 | $0.21 | $0.34 | $1.83 billion | $1.84 billion | Listen | |
| 10/24/2013 | Q3 2013 | $0.16 | $0.17 | $0.34 | $1.73 billion | $1.74 billion | Listen | |
| 7/25/2013 | Q2 2013 | $0.16 | $0.18 | $0.26 | $1.78 billion | $1.81 billion | Listen | |
| 4/25/2013 | Q1 2013 | $0.16 | $0.16 | $0.58 | $1.79 billion | $1.76 billion | Listen | |
| 1/29/2013 | Q4 2012 | $0.11 | $0.18 | | $1.76 billion | $1.82 billion | Listen | |
| 10/18/2012 | | $0.11 | ($0.52) | | | | N/A | |
| 7/26/2012 | | $0.08 | $0.17 | | | | Listen | |
| 4/19/2012 | | $0.13 | $0.15 | | | | N/A | |
| 2/2/2012 | | $0.08 | $0.07 | | | | N/A | |
| 10/20/2011 | | $0.09 | $0.15 | | | | N/A | |
| 7/28/2011 | | $0.08 | $0.17 | | | | N/A | |
| 4/20/2011 | | $0.04 | $0.01 | | | | N/A | |
| 2/1/2011 | | $0.09 | $0.15 | | | | N/A | |
| 10/19/2010 | Q3 2010 | $0.06 | $0.12 | $0.12 | | | N/A | |
| 7/20/2010 | Q2 2010 | $0.03 | $0.06 | $0.06 | | | N/A | |
| 4/26/2010 | Q1 2010 | $0.08 | $0.09 | $1.23 | | | N/A | |
| 2/10/2010 | Q4 2009 | $0.13 | $0.20 | $1.11 | | | N/A | |
| 10/19/2009 | Q3 2009 | $0.14 | $0.12 | $0.11 | | | N/A | |
| 7/20/2009 | Q2 2009 | $0.13 | $0.20 | $0.30 | | | N/A | |
| 4/20/2009 | Q1 2009 | $0.12 | $0.13 | $0.27 | | | N/A | |
| 1/28/2009 | Q4 2008 | $0.13 | $0.12 | $1.86 | | | N/A | |
| 10/21/2008 | Q3 2008 | $0.11 | $0.16 | $0.36 | | | N/A | |
| 7/21/2008 | Q2 2008 | $0.11 | $0.13 | $0.19 | | | N/A | |
| 4/21/2008 | Q1 2008 | $0.12 | $0.17 | $0.12 | | | N/A | |
| 2/4/2008 | Q4 2007 | $0.10 | $0.24 | $0.79 | | | N/A | |
(Earnings results data provided by Zacks Investment Research)
